Total Funding
80
51
Total FundingVenture - Series Unknown raised
Growth Score
-11 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
64435
StemCyte is specialized in the development of umbilical cord blood stem cell transplantation and therapeutic products.
- Tong-Young Lee: CEO
Robert Chow: Lead Founder
About the Company
StemCyte, Inc. operates as an umbilical cord blood stem cell transplantation and therapeutic products company. It provides cord blood products to transplant centers for life-threatening diseases. The company's products are used to treat patients suffering from various blood cancers, and immune and genetic disorders. StemCyte, Inc. was founded
in 1997 and is headquartered in Covina, California. It operates umbilical cord blood storage facilities in California and Taiwan. The company has locations in the United States, India, and Taiwan.
